TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells
Advanced Science · 2026
DOI: 10.1002/advs.202506995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yunhan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Membrane Glycoproteins, Receptors, Immunologic, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program: Intergovernmental International Science and Technology Innovation Cooperation Project, Outstanding Young Talents Project from Henan Province.
Abstract (Originalsprache)
Tumor‐associated macrophages (TAMs) predominantly exert functions that facilitate tumor progression. Triggering receptor expressed on myeloid cell 2 (TREM2) is expressed in TAMs, playing a crucial role in mediating the immunosuppressive function of TAMs. The mechanisms by which TREM2 + TAMs promote tumor growth and inhibit anti‐tumor immunity remain unclear. Through single‐cell sequencing of tumor tissues derived from wild‐type and Trem2 knockout mice bearing subcutaneous lung cancer, it is found that TREM2 deletion hindered tumor growth, with a notable increase in and improved functionality of CD4 + T and natural killer (NK) cells in the tumor microenvironment. TREM2 deficiency led to ATP‐binding cassette transporter A1 (ABCA1) downregulation, causing cholesterol accumulation in TAMs and promoting a pro‐inflammatory phenotype. This results in increased chemokine (C‐X3‐C motif) ligand 1 (CX3CL1) secretion of macrophages, recruiting more CD4 + T and NK cells to the tumor site, enhancing the anti‐tumor response. After screening food and drug administration (FDA)‐approved drugs, bortezomib and ataluren are found to effectively inhibit TREM2 expression in TAMs, indicating a potential therapeutic strategy against TREM2. This study elucidates the mechanism by which TREM2 shapes the immunosuppressive microenvironment and promotes tumorigenesis, highlighting TREM2 as a target for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
- Zhongyuan Cell Therapy and Immunotherapy Laboratory, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, 450052, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450052, China.
- State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan,…
- School of Public Health, Zhengzhou University, Zhengzhou, Henan, 450052, China.
ORCID-Profile: Yunhan Wang, Weina Yu, Xinxin Wang, Qitai Zhao, Aitian Li, Shasha Liu, Li Yang, Yi Zhang
Förderung
- National Natural Science Foundation of China
- National Key R&D Program: Intergovernmental International Science and Technology Innovation Cooperation Project
- Outstanding Young Talents Project from Henan Province
- Young and middle-aged Health Science and Technology Innovation Talents in Henan Province
- Science and Technology Innovation Team Support Plan from Henan Province
- Top Talent Plan from Zhengzhou University
- Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University
Zitieren
APA
Wang, Y., Yu, W., Wang, X., Zhao, Q., Lei, Q., Li, A., Liu, S., Wang, T., Yang, L., & Zhang, Y. (2026). TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells. Advanced Science. https://doi.org/10.1002/advs.202506995
Vancouver
Wang Y, Yu W, Wang X, Zhao Q, Lei Q, Li A, et al. TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells. Advanced Science. 2026. doi:10.1002/advs.202506995
BibTeX
@article{Wang2026,
author = {Wang, Yunhan and Yu, Weina and Wang, Xinxin and Zhao, Qitai and Lei, Qingyang and Li, Aitian and Liu, Shasha and Wang, Tian and Yang, Li and Zhang, Yi},
title = {TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202506995}
}
EUVIMED